Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of tumor angiogenesis as a therapeutic target in colorectal cancer
Francesca Battaglin, Alberto Puccini, Rossana Intini, et al.
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 3, pp. 251-266
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Triazole-fused pyrimidines in target-based anticancer drug discovery
Xing‐Jie Dai, Lei-Peng Xue, Shi‐Kun Ji, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115101-115101
Closed Access | Times Cited: 31
Anti‐angiogenesis in colorectal cancer therapy
Zhenni Yang, Xuqian Zhang, Xiaozhe Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 734-751
Open Access | Times Cited: 13
A Review of the Use of Native and Engineered Probiotics for Colorectal Cancer Therapy
Huawen Han, Yifan Zhang, Haibo Tang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3896-3896
Open Access | Times Cited: 8
Mechanism and strategies of immunotherapy resistance in colorectal cancer
Jiqi Shan, Dong Han, Chunyi Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 6
A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis
Stefania Rosano, Davide Corà, Sushant Parab, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 49
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
Kai Fang, Yueping Zhan, Ruiqiu Zhu, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 39
Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities
Maria Alba Sorolla, Iván Astola Hidalgo, Anabel Sorolla, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5037-5037
Open Access | Times Cited: 35
The Wnt/β-catenin signaling pathway in colorectal cancer: mechanism and intervention of traditional Chinese medicine and chemical compound
Sha Zeng, Juan Wang, Zhengrong Shi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Molecular Targets for the Treatment of Metastatic Colorectal Cancer
Romain Cohen, Thomas Pudlarz, Jean-François Delattre, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2350-2350
Open Access | Times Cited: 38
Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6/JAK2/STAT3 and p53/caspases-dependent signaling pathways based on molecular docking and in vitro study
Mohamed A. Tantawy, Nagla A. El-Sherbeeny, Nawal Helmi, et al.
Molecular and Cellular Biochemistry (2020) Vol. 469, Iss. 1-2, pp. 143-157
Closed Access | Times Cited: 34
NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets
Ashkan Bahrami, Amirreza Khalaji, Majed Bahri Najafi, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Molecular mechanism of angiogenesis in colorectal cancer
Portia Raphela-Choma, Mpho Choene, Lesetja R. Motadi
Gene Reports (2025), pp. 102163-102163
Open Access
Blocking Tumoral Angiogenesis VEGF/VEGFR Pathway: Bevacizumab—20 Years of Therapeutic Success and Controversy
Elena Chitoran, Vlad Rotaru, Daniela Cristina Stefan, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1126-1126
Open Access
Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer
Yanfeng Gao, Shuang Zhou, Yi Xu, et al.
Nitric Oxide (2018) Vol. 83, pp. 33-39
Open Access | Times Cited: 34
PTHrP treatment of colon cancer cells promotes tumor associated-angiogenesis by the effect of VEGF
Natalia Calvo, Pedro Carriere, María Julia Martín, et al.
Molecular and Cellular Endocrinology (2019) Vol. 483, pp. 50-63
Open Access | Times Cited: 27
Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients
Zizhen Zhang, Sheng Zheng, Yifeng Lin, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 25
Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies
Birgit Geoerger, Bruce Morland, Irène Jiménez, et al.
European Journal of Cancer (2021) Vol. 153, pp. 142-152
Open Access | Times Cited: 21
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies
Letizia Procaccio, Vera Damuzzo, Francesca Di Sarra, et al.
Drug Safety (2019) Vol. 42, Iss. 2, pp. 159-179
Closed Access | Times Cited: 25
α‑Solanine inhibits growth and metastatic potential of human colorectal cancer cells
Yan Xia, Miao Li, Lei Chen, et al.
Oncology Reports (2020)
Open Access | Times Cited: 22
Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer
Mengyuan Cao, Yunmeng Wang, Guige Lu, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 10, pp. 4447-4471
Open Access | Times Cited: 11
Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1
Heinz‐Josef Lenz, Guillem Argilés, Takayuki Yoshino, et al.
Clinical Colorectal Cancer (2020) Vol. 20, Iss. 1, pp. 84-95.e8
Open Access | Times Cited: 17
Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy
Hiroki Osumi, Eiji Shinozaki, Akira Ooki, et al.
Cancer Medicine (2020) Vol. 10, Iss. 2, pp. 615-625
Open Access | Times Cited: 16
SRSF3 Promotes Angiogenesis in Colorectal Cancer by Splicing SRF
Yinshuang Chen, Man Yang, Fanyi Meng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics
Teresa Di Desidero, Paola Orlandi, Anna Fioravanti, et al.
Biochemical Pharmacology (2019) Vol. 164, pp. 94-105
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top